Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction

BACKGROUNDS: Approximately 75% of bladder cancer occurrences are of the non-muscle-invasive type. The estimated five-year survival rate is 26%–55%. Currently, there is no reliable biomarker available for early diagnosis and prognosis of bladder cancer. The present study aims to identify a biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Xiaoyue, Qiang, Yujie, Zhang, Bo, Xu, Wei, Cui, Yali, Ma, Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667867/
https://www.ncbi.nlm.nih.gov/pubmed/36408130
http://dx.doi.org/10.3389/fonc.2022.1016542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667867/
https://www.ncbi.nlm.nih.gov/pubmed/36408130
http://dx.doi.org/10.3389/fonc.2022.1016542

Ejemplares similares